{
    "2021-07-06": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Psychedelic Startups Investors are Flocking To",
                "features": {
                    "keywords": [
                        "Psychedelic",
                        "Startups",
                        "Investors",
                        "Flocking"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-07-01",
                "original_text": "This Pharma Stock Is a Surefire Bet for July",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Surefire",
                        "Bet",
                        "July"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-06-15",
                "original_text": "Abbott's (ABT) DAPT for High Bleeding Risk Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Abbott",
                        "DAPT",
                        "High Bleeding Risk",
                        "FDA Approval"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}